According to a recent survey, 67% of people are bothered by fullness under the chin and its effect on their appearance. Submental fullness, commonly referred to as “double chin”, can affect both men and women and may appear due to genetic factors, weight gain, or aging. A person does not need to be overweight to have fullness under the chin. In fact, the condition may not improve or go away, even with proper diet and exercise.
Also known as Kybella® in the United States, Belkyra™ is a prescription medicine injected under the chin. It is the only injectable treatment approved by Health Canada to improve the appearance and profile of adults with moderate to severe submental fullness (double chin).
The active ingredient in Belkyra™ is synthetic deoxycholic acid which is a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected beneath the chin, Belkyra™ removes fat cells, thus reducing fullness under the chin, and improving the facial profile. Patients generally require two to six treatments, spaced approximately six weeks apart. After your desired aesthetic outcome has been achieved, further treatment is not expected.
If you are an adult bothered by "double chin fat" and wish to avoid surgery, please contact us for more information about Belkyra™.